Ngapas, Acmad N.
HRN: 28-10-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
CEFTRIAXONE 1G (VIAL)
11/13/2025
11/20/2025
IV
2g
OD
T/C Pneumothorax Right LF, PTB, Category I, Lost To Followup, To Rule Out PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes